BMO Capital raised the firm’s price target on Aritzia (ATZAF) to C$80 from C$68 and keeps an Outperform rating on the shares.Maximize Your ...

BMO Capital raised the firm’s price target on CAE (CAE) to C$39 from C$38 and keeps an Outperform rating on the shares.Maximize Your Portfolio ...

BMO Capital Markets. "As the industry evolves, our priority is providing exceptional service to our clients while delivering more integrated and innovative solutions to grow our market leading ...

BMO Capital Markets. "As the industry evolves, our priority is providing exceptional service to our clients while delivering more integrated and innovative solutions to grow our market leading ...

GrafTech International (NYSE:EAF – Get Free Report) had its price objective cut by stock analysts at BMO Capital Markets from $2.00 to $1.50 in a report issued on Monday,Benzinga reports.

Alimentation Couche-Tard (TSE:ATD – Get Free Report) had its target price dropped by investment analysts at BMO Capital Markets from C$87.00 to C$85.00 in a research report issued on Monday ...

On Tuesday, BMO Capital Markets reaffirmed their Outperform rating on Beam Therapeutics Inc (NASDAQ:BEAM), with a steady price target of $57.00. Currently trading at $26.57, the stock appears ...

Tuesday, BMO Capital Markets highlighted the potential risks faced by Real Estate Investment Trusts (REITs) specializing in Skilled Nursing Facilities (SNFs) due to possible changes in Federal ...

BMO Capital Markets adjusted their outlook on DuPont (NYSE:DD), increasing the price target from the previous $105.00 to a ...

Tuesday, BMO Capital Markets highlighted the potential risks faced by Real Estate Investment Trusts (REITs) specializing in Skilled Nursing Facilities (SNFs) due to possible changes in Federal Medical ...

On Tuesday, BMO Capital Markets reaffirmed their Outperform rating on Beam Therapeutics Inc (NASDAQ:BEAM), with a steady price target of $57.00. Currently trading at $26.57, the stock appears ...

BMO Capital Markets initiated coverage on Flowco Holdings (NYSE:FLOC) with an Outperform rating and a price target of $33.00, representing a potential upside from the current price of $28.65. The firm ...